InvestorsHub Logo
Followers 0
Posts 104
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Thursday, 05/24/2018 9:07:11 AM

Thursday, May 24, 2018 9:07:11 AM

Post# of 19459
NIH grant for Zika.
GeoVax Awarded NIH Grant for Novel Zika Vaccine
https://finance.yahoo.com/news/geovax-awarded-nih-grant-novel-130000314.html
The grant, entitled “Advanced Preclinical Testing of a Novel Recombinant Vaccine Against Zika Virus”, supports advanced preclinical testing of GeoVax’s vaccine candidate (designated GEO-ZM02) in non-human primates in preparation for human clinical trials. GEO-ZM02 is a novel vaccine approach to protect against Zika virus (ZIKV), using GeoVax’s Modified Vaccinia Ankara (MVA) vector to express the ZIKV non-structural protein 1 (NS1).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News